# PREVENT: Promus BTK

> **NCT01500070** · PHASE2 · COMPLETED · sponsor: **Flanders Medical Research Program** · enrollment: 70 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** Everolimus-Eluting Stent (PROMUS ELEMENT)

## Key facts

- **NCT ID:** NCT01500070
- **Lead sponsor:** Flanders Medical Research Program
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2016-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01500070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01500070, "PREVENT: Promus BTK". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01500070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*